Experts warn in a report summarizing 50 peer-reviewed studies that experimental use of puberty suppressants to treat gender dysphoria could pose serious risks to young patients.
By Joan Frawley Desmond, EWTN News, 6/22/17
WASHINGTON — When a psychiatrist and research fellow at the Yale School of Medicine recently advocated the use of “puberty blockers” for children dealing with gender-identity issues, in an opinion column for The New York Times, a flood of reader comments accused the physician of supporting treatment that amounted to “child abuse.”